Guidelines for clinical application of Chinese patent medicine in the treatment of influenza in children(2024)
Ziteng Hu
Ning Liang
Xi Ming
Lijiao Yan
Xuefei Zhang
Yujing Zhang
Yaxin Chen
Yijiu Yang
Xuefeng Wang
Lining Wang
Liqun Wu
Baoqing Zhang
Ke Chang
Hua Chen
Xiaochun Feng
Jian Gao
Xiuan Gao
Jijun Li
Min Li
Xinmin Li
Yanhong Qin
Xianqing Ren
Gao Sang
Liping Sun
Yuanling Sun
Bo Wang
Mengqing Wang
Sumei Wang
Xiao Wang
Youpeng Wang
Li Wu
Zhenqi Wu
Zheng Xue
Jianer Yu
Xiuying Zhang
Xia Zhang
Xia Zhao
Yanping Wang
Rong Ma
Lei Xiong
Nannan Shi
摘要：Children are highly susceptible to influenza and are at high risk for severe cases.Chinese patent medicine(CPM)offers advantages in treating pediatric influenza,but the issue of its improper use is increasingly prevalent in clinical practice.To address this,we adopted a dual leadership approach involving clinical and methodological experts,guided by evidence-based and clinical practice principles.We referred to existing guidelines,consensus statements,and treatment protocols,and designed relevant clinical questions based on the"3 specific"principles:specific CPM,specific disease stages,and specific outcomes.This allowed us to conduct evidence-based evaluations of the efficacy and application of CPMs specifically designed for children or with pediatric dosages.Using the"Checklist for Reporting Clinical Practice Guidelines for Chinese Patent Medicines V1.0"developed by our research team,we formulated recommendations for CPM.Ultimately,13 CPMs were recommended,providing clinicians with references on"how to select medication"and"how to use medication."
机标关键词：applicationmedicinechinesechildrenclinicalguidelinesinfluenzapatent
论文发表日期：2024-12-30
页数：15( 141-155 )
英文信息